TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 49 filers reported holding TYRA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,198 | -12.2% | 22,164 | +8.6% | 0.00% | – |
| Q2 2023 | $347,616 | -62.7% | 20,412 | -64.8% | 0.00% | – |
| Q1 2023 | $932,236 | +485.2% | 58,011 | +176.7% | 0.00% | – |
| Q4 2022 | $159,312 | +31.7% | 20,962 | +52.0% | 0.00% | – |
| Q3 2022 | $121,000 | -14.2% | 13,791 | -30.1% | 0.00% | – |
| Q2 2022 | $141,000 | -79.4% | 19,719 | -69.2% | 0.00% | – |
| Q1 2022 | $686,000 | +757.5% | 64,126 | +1020.1% | 0.00% | – |
| Q4 2021 | $80,000 | +433.3% | 5,725 | +546.9% | 0.00% | – |
| Q3 2021 | $15,000 | – | 885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $47,187,000 | 19.65% |
| Nextech Invest Ltd. | 2,518,582 | $26,949,000 | 7.69% |
| TCG Crossover Management, LLC | 896,418 | $9,592,000 | 3.85% |
| Boxer Capital, LLC | 6,448,359 | $68,997,000 | 3.55% |
| Fairmount Funds Management LLC | 1,284,990 | $13,749,000 | 3.25% |
| RA Capital Management | 7,236,454 | $77,430,000 | 1.69% |
| Frazier Life Sciences Management, L.P. | 1,327,665 | $14,206,000 | 1.21% |
| BVF INC/IL | 2,472,327 | $26,454,000 | 1.06% |
| Cormorant Asset Management, LP | 757,432 | $8,105,000 | 0.62% |
| Sio Capital Management, LLC | 111,033 | $1,188,000 | 0.39% |